Google parent company Alphabet Inc. has launched a new company in London called Isomorphic Labs. The company aims to use AI (artificial intelligence) for drug discovery and medicine to find cures for some of humanity’s most devastating diseases. Demis Hassabis will be the CEO of Isomorphic Labs. Hassabis is the CEO and co-founder of DeepMind, another Alphabet subsidiary that used AI to predict the 3D structure of a protein directly from its amino acid sequence.
The London-based Isomorphic Labs will work on the most important applications of AI — in the field of biological and medical research. The company aims to use AI to accelerate drug discovery, and ultimately, find cures for some of humanity’s most devastating diseases. The new venture also plans to partner with biomedical and pharmaceutical companies, using artificial intelligence to discover new medicinal advancements.
Important takeaways for all competitive exams
Mangrol, the third ASW-SWC, which has more than 80% indigenous content, was handed over to…
India has come up with its first-ever Soil Texture Map by the National Bureau of…
President Droupadi Murmu will present the National Teachers’ Awards 2026 on 5 September 2026 (Teachers'…
Mobile Phone Manufacturing Scheme (MPMS) of INR 62,500 Crore has been announced by the Centre…
Sophie Adenot is a French engineer, helicopter test pilot, military officer and European Space Agency…
The technology for the development of Submarine-Fired Decoy (SFD) has been handed over to Bharat…